OSTX
Os Therapies Announces Pricing of $6 Million Private Placement
时间：2024-12-24 22:32:00 市场： 美股 综合
Os Therapies: Colin Goddard Notified Board of His Resignation as Chairman of Board
时间：2024-10-29 04:59:07 市场： 美股 综合
Os Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of Directors
时间：2024-10-29 04:44:00 市场： 综合 美股
Os Therapies Announces Last Patient Enrolled in Ost-Her2 Osteosarcoma Phase 2B Clinical Trial Completes Last Patient Visit
时间：2024-10-03 20:00:03 市场： 美股 综合
Os Therapies Inc - to Ring Closing Bell at Nyse on Oct 3, 2024
时间：2024-10-03 20:00:03 市场： 美股 综合
Os Therapies Announces Development of Two Novel Tunable Antibody Drug Conjugate (Tadc)-Based Therapeutic Candidates
时间：2024-09-13 20:09:00 市场： 美股 综合
Os Therapies Inc: Announced Positive Data in Animal Models of Ovarian Cancer for First Therapeutic Candidate Developed Using Tadc Platform
时间：2024-09-11 20:26:20 市场： 美股 综合